Disclosure Of Fair Value Measurement [Text Block]

Innate Pharma - Filing #2821023

Concept	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	—	—	—	—	307 423 EUR	—	—	401 361 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	156 476 EUR	63 984 EUR	3 950 EUR	372 131 EUR	355,000 EUR	155 976 EUR	20 759 EUR	369 617 EUR	217 416 EUR	134 912 EUR	3 941 EUR	472,000 EUR	3 197 EUR	299 932 EUR	137 961 EUR	167 119 EUR	3 049 EUR	1 099 EUR	121,000 EUR	299 932 EUR	167 240 EUR	1 099 EUR	3 049 EUR	3 197 EUR	137 840 EUR	121,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]